Pfizer launches novel programs to put important support services at the fingertips of cancer patients
- Details
- Category: Pfizer
Pfizer today unveils enhanced offerings to help patients manage their life with cancer. Pfizer Oncology Together is a first-of-its-kind program for patients taking Pfizer Oncology medicines that offers dedicated social workers called 'Care Champions' to help navigate the complexities that accompany treatment, such as identifying resources to help find emotional support, and workplace transition, transportation and financial assistance.
Caregivers wish liver cancer received greater public awareness in the U.S., new survey reveals
- Details
- Category: Bristol-Myers Squibb
Bristol-Myers Squibb Company (NYSE:BMY), in collaboration with Blue Faery: The Adrienne Wilson Liver Cancer Association, a leading liver cancer patient advocacy organization, today announced the findings from a new survey exploring the experiences of caregivers of people living with early or advanced stage liver cancer in the U.S.
Amgen and CytomX Therapeutics announce strategic collaboration in immuno-oncology
- Details
- Category: Amgen
Amgen (NASDAQ:AMGN) and CytomX Therapeutics, Inc., (NASDAQ:CTMX) today announced that the companies have entered into a strategic collaboration in immuno-oncology. The companies will co-develop a CytomX ProbodyTM T-cell engaging bispecific against the Epidermal Growth Factor Receptor (EGFR), a highly validated oncology target expressed on multiple human cancer types.
Abbott acquisition of Alere set to close on Tuesday, October 3, 2017
- Details
- Category: Abbott
Abbott (NYSE: ABT) intends to close the acquisition of Alere, Inc., on Tuesday, Oct. 3, 2017. The announcement follows receipt of all regulatory clearances necessary for closing. The transaction establishes Abbott as the global leader in point of care testing - the fastest-growing segment of the $50 billion in vitro diagnostics market - and further strengthens the company's diagnostics presence.
IDF and Novo Nordisk launch first-ever global survey on cardiovascular disease awareness among people with type 2 diabetes
- Details
- Category: Novo Nordisk
To mark World Heart Day today, the International Diabetes Federation (IDF) has partnered with Novo Nordisk to launch the first-ever multi-country online survey investigating the level of CVD awareness and knowledge among people living with type 2 diabetes. The global survey - Taking Diabetes to Heart - is available in multiple languages until March 2018, and people with type 2 diabetes are encouraged to participate.
Novartis and UC Berkeley collaborate to tackle 'undruggable' disease targets
- Details
- Category: Novartis
Novartis has joined forces with researchers from the University of California, Berkeley, to develop new technologies for the discovery of next-generation therapeutics, pursuing the vast number of disease targets in cancer and other illnesses that have eluded traditional small-molecule compounds and are considered "undruggable."
Amgen and Simcere announce strategic collaboration to co-develop and commercialize biosimilars in China
- Details
- Category: Amgen
Amgen (NASDAQ: AMGN) and Simcere Pharmaceutical Group have announced the execution of an exclusive agreement to co-develop and commercialize four biosimilars in China. The collaboration includes undisclosed biosimilars in the areas of inflammation and oncology.
More Pharma News ...
- Up to $20,000 available to the digital health company that solves one of the challenges proposed by MSD
- Daiichi Sankyo announces TaNeDS Global 2018 collaborative drug discovery program
- Bevespi Aerosphere demonstrates statistically significant improvement in lung function in patients with COPD
- Amgen Foundation pledges up to $5 million to Hurricane Maria relief efforts
- AbbVie and Bristol-Myers Squibb announce clinical research collaboration to evaluate a therapeutic regimen in advanced solid tumors
- Novartis and The Max Foundation transform pioneering cancer access program for people in lower-income countries
- New scholarships worth EUR 417,000 awarded by Bayer Foundation to promote international talents